- Home
- ENZ vs CSBR Comparison
ENZ vs CSBR Comparison
Compare ENZ & CSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENZ
- CSBR
- Stock Information
- Founded
- ENZ 1976
- CSBR 1985
- Country
- ENZ United States
- CSBR United States
- Employees
- ENZ N/A
- CSBR N/A
- Industry
- ENZ Medical Specialities
- CSBR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ENZ Health Care
- CSBR Health Care
- Exchange
- ENZ Nasdaq
- CSBR Nasdaq
- Market Cap
- ENZ 59.7M
- CSBR 65.9M
- IPO Year
- ENZ N/A
- CSBR 1986
- Fundamental
- Price
- ENZ $1.03
- CSBR $4.50
- Analyst Decision
- ENZ
- CSBR Strong Buy
- Analyst Count
- ENZ 0
- CSBR 1
- Target Price
- ENZ N/A
- CSBR $6.00
- AVG Volume (30 Days)
- ENZ 122.4K
- CSBR 11.7K
- Earning Date
- ENZ 12-13-2024
- CSBR 12-10-2024
- Dividend Yield
- ENZ 9.62%
- CSBR N/A
- EPS Growth
- ENZ N/A
- CSBR N/A
- EPS
- ENZ N/A
- CSBR N/A
- Revenue
- ENZ $31,907,000.00
- CSBR $51,655,000.00
- Revenue This Year
- ENZ N/A
- CSBR $9.27
- Revenue Next Year
- ENZ N/A
- CSBR $9.76
- P/E Ratio
- ENZ N/A
- CSBR N/A
- Revenue Growth
- ENZ 2.72
- CSBR N/A
- 52 Week Low
- ENZ $0.99
- CSBR $3.60
- 52 Week High
- ENZ $1.50
- CSBR $7.13
- Technical
- Relative Strength Index (RSI)
- ENZ 30.02
- CSBR 54.07
- Support Level
- ENZ $1.09
- CSBR $4.30
- Resistance Level
- ENZ $1.18
- CSBR $4.70
- Average True Range (ATR)
- ENZ 0.04
- CSBR 0.24
- MACD
- ENZ -0.01
- CSBR 0.06
- Stochastic Oscillator
- ENZ 5.88
- CSBR 78.95
About ENZ Enzo Biochem Inc. ($0.01 Par Value)
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. It focuses on delivering and applying its technology to produce products and services to allow its customers to meet their clinical needs. The company has Enzo clinical labs, Enzo life sciences, Enzo therapeutics operating segments. It derives the majority of its revenues from the Clinical lab's segment.
About CSBR Champions Oncology Inc.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.